(19)
(11) EP 2 316 479 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.03.2015 Bulletin 2015/12

(45) Mention of the grant of the patent:
03.12.2014 Bulletin 2014/49

(21) Application number: 10075630.3

(22) Date of filing: 18.07.2003
(51) International Patent Classification (IPC): 
A61K 39/245(2006.01)
C12N 7/00(2006.01)
 C07K 14/005(2006.01)
A61K 39/00(2006.01)

(54)

Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments

Pharmazeutische Zusammensetzungen, die immunologisch aktive Herpes simplex Virus Proteinfragmente enthalten

Compositions pharmaceutiques comportant des fragments de protéine du virus de l'herpès simplex d'acitvité immunologique

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 18.07.2002 US 396791 P

(43) Date of publication of application:
04.05.2011 Bulletin 2011/18

(60) Divisional application:
14195732.4

(62) Application number of the earlier application in accordance with Art. 76 EPC:
08166335.3 / 2011510
03765758.2 / 1523582

(73) Proprietor: University of Washington
Seattle, WA 98105-4608 (US)

(72) Inventors:
  • Corey, Lawrence
    Mercer Island, WA 98040 (US)
  • Koelle, David M.
    Seattle, WA 98105 (US)
  • Liu, Zhi
    Shoreline, WA 98177 (US)

(74) Representative: Cornish, Kristina Victoria Joy et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)


(56) References cited: : 
WO-A-01/23414
WO-A2-03/086308
US-B1- 6 375 952
 WO-A-98/20016
US-A- 5 747 039
   
  • DOLAN A ET AL: "The genome sequence of herpes simplex virus type 2", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 72, no. 3, March 1998 (1998-03), pages 2010-2021, XP002964837, ISSN: 0022-538X
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).